Cargando…
KAI1(CD82) is a key molecule to control angiogenesis and switch angiogenic milieu to quiescent state
BACKGROUND: Little is known about endogenous inhibitors of angiogenic growth factors. In this study, we identified a novel endogenous anti-angiogenic factor expressed in pericytes and clarified its underlying mechanism and clinical significance. METHODS: Herein, we found Kai1 knockout mice showed si...
Autores principales: | Lee, Jin-Woo, Hur, Jin, Kwon, Yoo-Wook, Chae, Cheong-Whan, Choi, Jae-Il, Hwang, Injoo, Yun, Ji-Yeon, Kang, Jin-A, Choi, Young-Eun, Kim, Young Hyun, Lee, Sang Eun, Lee, Cheol, Jo, Dong Hyun, Seok, Heeyoung, Cho, Byong Seung, Baek, Sung Hee, Kim, Hyo-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444549/ https://www.ncbi.nlm.nih.gov/pubmed/34530889 http://dx.doi.org/10.1186/s13045-021-01147-6 |
Ejemplares similares
-
Recombinant human KAI1/CD82 attenuates M1 macrophage polarization on LPS-stimulated RAW264.7 cells via blocking TLR4/JNK/NF-κB signal pathway
por: Lee, Hyesook, et al.
Publicado: (2023) -
The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling
por: Lee, Jaeseob, et al.
Publicado: (2016) -
Kai 1 and Kai 2: Characterization of these dog erythrocyte antigens by monoclonal antibodies
por: Lee, Jae Ho, et al.
Publicado: (2017) -
Targeting CD82/KAI1 for Precision Therapeutics in Surmounting Metastatic Potential in Breast Cancer
por: Viera, Maximillian, et al.
Publicado: (2021) -
Role of Metastasis Suppressor KAI1/CD82 in Different Cancers
por: Yan, Wei, et al.
Publicado: (2021)